Lack of any changes in genes that are typically altered early in Pcp2-ATXN2[Q127] and BAC-Q72 supports the notion that simple overexpression of human wild-type ATXN2 does not cause significant PC pathology. This evidence concerns the gene ATXN2 and pachyonychia congenita.